| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Freeman Kevin D is a Director at GALECTIN THERAPEUTICS INC. Recent SEC Form 4 filings include 10 buys and 0 sells.
Estimated insider holdings value: $116K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 19, 2022 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $1.96 | $9,806.00 | +11.1% | -15.4% | -43.3% | |
| Dec 6, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.28 | $11,400.00 | +11.1% | -25.8% | -49.6% | |
| Dec 6, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.34 | $11,700.00 | +12.5% | -25.8% | -49.6% | |
| Oct 29, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 2,000 | $3.17 | $6,340.00 | +5.3% | -42.6% | -56.2% | |
| Oct 21, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 2,000 | $3.19 | $6,380.00 | +5.6% | -37.6% | -53.4% | |
| Oct 19, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 3,000 | $3.37 | $10,106.70 | +9.1% | -41.9% | -53.6% | |
| Sep 23, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 3,000 | $3.88 | $11,631.00 | +10.0% | -42.2% | -58.8% | |
| Apr 5, 2021 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.04 | $10,200.00 | +20.0% | +40.1% | -21.7% | |
| Sep 4, 2020 | GALT Galectin Therapeutics Inc | Director | Buy | 5,000 | $2.57 | $12,848.00 | +25.0% | - | - | |
| Mar 19, 2020 | GALT Galectin Therapeutics Inc | Director | Buy | 6,000 | $1.64 | $9,844.20 | +42.9% | - | - |